Category : Clinical Research, Pharma & Healthcare Financing

MODERNISED (NIHR207538), a multi-site UK clinical study has passed a key milestone: over 450 participants have joined the trial evaluating ENLIGHTEN®, a first-of-its-kind blood test, registered with...

Akeso, Inc. (9926.HK) (“Akeso” or the “Company”) announced that the first patient has been dosed in its pivotal Phase III clinical study (AK112-305/HARMONi-8A) of ivonescimab...

This acquisition enables ESTEVE to expand its contract development and manufacturing services for small-molecule active pharmaceutical ingredients from pre-clinical to commercial manufacturing in the US. ...

New ctDNA-based test offers a flexible, guideline-driven solution for patients with advanced solid tumors when tissue is limited or unavailable NeoGenomics, Inc. (NASDAQ: NEO), a...

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced construction has begun for a new modular Drug Product (DP) facility,...

Pirtobrutinib met the primary endpoint of response rate non-inferiority, favoring pirtobrutinib with a nominal P-value for superiority < 0.05 Progression-free survival data was immature, but...

Non-dilutive funding advances development of differentiated ribosome-targeting antibiotics for serious, drug-resistant infections with high unmet patient need Kinvard Bio Inc., a biotechnology company pioneering a next-generation class...

Azafaros, a company focused on developing treatments for the unmet needs of patients with rare lysosomal storage disorders, today announced that the first patient has...

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapies™ (MET) dedicated to enhancing survival...

Two transformative healthcare announcements this week mark a new era for New Jersey’s innovation economy—with Garden State Venture Partners (GSVP) emerging as a key catalyst...

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) Abivax SA (Euronext Paris: FR0012333284 –...

Kling Bio (“Kling” or “the Company”), a biotech company developing antibody-based drugs for cancer and infectious diseases, today announced it has entered into a collaboration and...

SurgiBind® Tendon Protect designed for preserving motion in surgical tendon management procedures without substantial tissue loss Kerecis, the company pioneering the use of fish-tissue in...